212 related articles for article (PubMed ID: 26440310)
21. Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas.
Reifenberger J; Knobbe CB; Sterzinger AA; Blaschke B; Schulte KW; Ruzicka T; Reifenberger G
Int J Cancer; 2004 Apr; 109(3):377-84. PubMed ID: 14961576
[TBL] [Abstract][Full Text] [Related]
22. MYC high level gene amplification is a distinctive feature of angiosarcomas after irradiation or chronic lymphedema.
Manner J; Radlwimmer B; Hohenberger P; Mössinger K; Küffer S; Sauer C; Belharazem D; Zettl A; Coindre JM; Hallermann C; Hartmann JT; Katenkamp D; Katenkamp K; Schöffski P; Sciot R; Wozniak A; Lichter P; Marx A; Ströbel P
Am J Pathol; 2010 Jan; 176(1):34-9. PubMed ID: 20008140
[TBL] [Abstract][Full Text] [Related]
23. Mitogen-activated protein kinase signaling is activated in prostate tumors but not mediated by B-RAF mutations.
Burger M; Denzinger S; Hammerschmied C; Tannapfel A; Maderstorfer A; Wieland WF; Hartmann A; Stoehr R
Eur Urol; 2006 Nov; 50(5):1102-9; discussion 1109-10. PubMed ID: 16413100
[TBL] [Abstract][Full Text] [Related]
24. Comparative Genomics Reveals Shared Mutational Landscape in Canine Hemangiosarcoma and Human Angiosarcoma.
Megquier K; Turner-Maier J; Swofford R; Kim JH; Sarver AL; Wang C; Sakthikumar S; Johnson J; Koltookian M; Lewellen M; Scott MC; Schulte AJ; Borst L; Tonomura N; Alfoldi J; Painter C; Thomas R; Karlsson EK; Breen M; Modiano JF; Elvers I; Lindblad-Toh K
Mol Cancer Res; 2019 Dec; 17(12):2410-2421. PubMed ID: 31570656
[TBL] [Abstract][Full Text] [Related]
25. Porocarcinomas harbor recurrent HRAS-activating mutations and tumor suppressor inactivating mutations.
Harms PW; Hovelson DH; Cani AK; Omata K; Haller MJ; Wang ML; Arps D; Patel RM; Fullen DR; Wang M; Siddiqui J; Andea A; Tomlins SA
Hum Pathol; 2016 May; 51():25-31. PubMed ID: 27067779
[TBL] [Abstract][Full Text] [Related]
26. Skin tumors induced by sorafenib; paradoxic RAS-RAF pathway activation and oncogenic mutations of HRAS, TP53, and TGFBR1.
Arnault JP; Mateus C; Escudier B; Tomasic G; Wechsler J; Hollville E; Soria JC; Malka D; Sarasin A; Larcher M; André J; Kamsu-Kom N; Boussemart L; Lacroix L; Spatz A; Eggermont AM; Druillennec S; Vagner S; Eychène A; Dumaz N; Robert C
Clin Cancer Res; 2012 Jan; 18(1):263-72. PubMed ID: 22096025
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathologic assessment of postradiation sarcomas: KIT as a potential treatment target.
Komdeur R; Hoekstra HJ; Molenaar WM; Van Den Berg E; Zwart N; Pras E; Plaza-Menacho I; Hofstra RM; Van Der Graaf WT
Clin Cancer Res; 2003 Aug; 9(8):2926-32. PubMed ID: 12912938
[TBL] [Abstract][Full Text] [Related]
28. A transcriptome signature of endothelial lymphatic cells coexists with the chronic oxidative stress signature in radiation-induced post-radiotherapy breast angiosarcomas.
Hadj-Hamou NS; Laé M; Almeida A; de la Grange P; Kirova Y; Sastre-Garau X; Malfoy B
Carcinogenesis; 2012 Jul; 33(7):1399-405. PubMed ID: 22532251
[TBL] [Abstract][Full Text] [Related]
29. Post-radiotherapy vascular lesions of the breast: immunohistochemical and molecular features of 74 cases with long-term follow-up and literature review.
Corradini AG; Asioli S; Morandi L; Brotto M; Righi A; Iommi M; Agostinelli C; Rucci P; Asioli S; Sapino A; Viale G; Foschini MP
Histopathology; 2020 Aug; 77(2):293-302. PubMed ID: 32043616
[TBL] [Abstract][Full Text] [Related]
30. Mitogen-Activated Protein Kinase Pathway: Genetic Analysis of 95 Adrenocortical Tumors.
Rubin B; Monticelli H; Redaelli M; Mucignat C; Barollo S; Bertazza L; Mian C; Betterle C; Iacobone M; Fassina A; Boscaro M; Pezzani R; Mantero F
Cancer Invest; 2015; 33(10):526-31. PubMed ID: 26536286
[TBL] [Abstract][Full Text] [Related]
31. Mutational activation of the RAS-RAF-MAPK and the Wnt pathway in small intestinal adenocarcinomas.
Bläker H; Helmchen B; Bönisch A; Aulmann S; Penzel R; Otto HF; Rieker RJ
Scand J Gastroenterol; 2004 Aug; 39(8):748-53. PubMed ID: 15513360
[TBL] [Abstract][Full Text] [Related]
32. Recurrent PTPRB and PLCG1 mutations in angiosarcoma.
Behjati S; Tarpey PS; Sheldon H; Martincorena I; Van Loo P; Gundem G; Wedge DC; Ramakrishna M; Cooke SL; Pillay N; Vollan HKM; Papaemmanuil E; Koss H; Bunney TD; Hardy C; Joseph OR; Martin S; Mudie L; Butler A; Teague JW; Patil M; Steers G; Cao Y; Gumbs C; Ingram D; Lazar AJ; Little L; Mahadeshwar H; Protopopov A; Al Sannaa GA; Seth S; Song X; Tang J; Zhang J; Ravi V; Torres KE; Khatri B; Halai D; Roxanis I; Baumhoer D; Tirabosco R; Amary MF; Boshoff C; McDermott U; Katan M; Stratton MR; Futreal PA; Flanagan AM; Harris A; Campbell PJ
Nat Genet; 2014 Apr; 46(4):376-379. PubMed ID: 24633157
[TBL] [Abstract][Full Text] [Related]
33. Cytogenetic analysis of four angiosarcomas from deep and superficial soft tissue.
Schuborg C; Mertens F; Rydholm A; Brosjö O; Dictor M; Mitelman F; Mandahl N
Cancer Genet Cytogenet; 1998 Jan; 100(1):52-6. PubMed ID: 9406581
[TBL] [Abstract][Full Text] [Related]
34. Characterization of active mitogen-activated protein kinase in ovarian serous carcinomas.
Hsu CY; Bristow R; Cha MS; Wang BG; Ho CL; Kurman RJ; Wang TL; Shih IeM
Clin Cancer Res; 2004 Oct; 10(19):6432-6. PubMed ID: 15475429
[TBL] [Abstract][Full Text] [Related]
35. Angiogenesis-related gene mutations drive a subset of angiosarcomas.
Cancer Discov; 2014 May; 4(5):OF18. PubMed ID: 24795022
[TBL] [Abstract][Full Text] [Related]
36. MDM-2 oncoprotein overexpression, p53 gene mutation, and VEGF up-regulation in angiosarcomas.
Zietz C; Rössle M; Haas C; Sendelhofert A; Hirschmann A; Stürzl M; Löhrs U
Am J Pathol; 1998 Nov; 153(5):1425-33. PubMed ID: 9811333
[TBL] [Abstract][Full Text] [Related]
37. Genomic profile of breast sarcomas: a comparison with malignant phyllodes tumours.
Lim SZ; Ng CCY; Rajasegaran V; Guan P; Selvarajan S; Thike AA; Nasir NDBM; Koh VCY; Tan BKT; Ong KW; Teh BT; Tan PH
Breast Cancer Res Treat; 2019 Apr; 174(2):365-373. PubMed ID: 30511242
[TBL] [Abstract][Full Text] [Related]
38. Genetic context of oncogenic drivers dictates vascular sarcoma development in aP2-Cre mice.
Hanna JA; Langdon CG; Garcia MR; Benton A; Lanman NA; Finkelstein D; Rehg JE; Hatley ME
J Pathol; 2022 May; 257(1):109-124. PubMed ID: 35066877
[TBL] [Abstract][Full Text] [Related]
39. Molecular subtypes in canine hemangiosarcoma reveal similarities with human angiosarcoma.
Wang G; Wu M; Durham AC; Radaelli E; Mason NJ; Xu X; Roth DB
PLoS One; 2020; 15(3):e0229728. PubMed ID: 32210430
[TBL] [Abstract][Full Text] [Related]
40. Recurrent Alterations in the MAPK pathway in Sporadic Pyogenic Granuloma of Childhood.
Strobel K; Maurus K; Hamm H; Roth S; Goebeler M; Rosenwald A; Wobser M
Acta Derm Venereol; 2022 May; 102():adv00715. PubMed ID: 35393626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
